Residency & Fellowship
Infectious Diseases Pharmacotherapy Residency (PGY2)
About the Program
The PGY-2 Infectious Diseases Pharmacotherapy Residency with the University of Houston College of Pharmacy and Cardinal Health Pharmacy Management Services is a 12-month residency experience in the heart of the Texas Medical Center (TMC), the world's largest medical center with more than 50 separate healthcare institutions.
The primary practice sites will be St. Luke's Episcopal Hospital and Cardinal Health Pharmacy Management Services, with elective opportunities at several TMC institutions. Through required and elective rotations, the residency program is designed to develop expertise and clinical competence in pharmacotherapeutic, technological, and stewardship aspects of infectious diseases in various practice settings.
The clinical experience coupled with didactic training in the basic science of infectious diseases will prepare the resident to evaluate therapeutic questions related to infections in a multitude of patient populations. In addition, the resident will become an integral part of the Houston Infectious Disease Network, interacting with a number of ID pharmacy clinicians and educators within the TMC.
The applicant must possess a Pharm.D. degree and PGY1 pharmacy practice residency or equivalent experience. Licensure in the state of Texas is required. Applicants must submit curriculum vitae, a letter of intent, an official copy of transcripts (either mailed with packet or directly from institution) and three letters of reference to the following address by January 10, 2014:
Elizabeth A. Coyle, Pharm.D., FCCM, BCPS
Assistant Dean of Assessment
Director, ID Residency Program
University of Houston College of Pharmacy
1441 Moursund Ave.
Houston, TX 77030
Note to applicants: The UHCOP/Cardinal Health PGY-2 Infectious Diseases Residency is not an ASHP-accredited residency. Program administrators intend to submit the program for accreditation consideration.
Institutional Roles in Residency
University of Houston College of Pharmacy
Founded in 1946, the University of Houston College of Pharmacy (UHCOP) combines the opportunities and experiences of the Texas Medical Center's world-class healthcare community with resources of the University of Houston to offer its students the best possible education in pharmacy. The College is accredited by the Accreditation Council for Pharmacy Education and holds membership in the American Association of Colleges of Pharmacy.
The College's Clinical Sciences and Administration Department is home to several nationally and internationally recognized faculty members with clinical and/or research practice in the area of Infectious Diseases. A proud member of the Texas Medical Center (TMC) for more than 30 years, the College provides optimal opportunities for interaction with practitioners from several renowned TMC institutions.
The resident will be based out of UHCOP's TMC Campus, with space allotted for the resident's work functions and where most of the resident's teaching responsibilities will be conducted. As desired, the resident also will have the opportunity to work in the Anti-Infective Research Laboratories in the UHCOP TMC Campus building. With more than six infectious diseases faculty (including the residency director) based within the same facility, the resident will be provided with unique opportunities for attaining professional growth as a clinician and academician.
Cardinal Health Pharmacy Services
Cardinal Health is a global healthcare business company and provider of pharmacy management services to acute care hospitals. Currently, Cardinal manages over 200 acute care hospitals that range in size from six to 1,000 beds. Cardinal's focus is on improving patient outcomes delivered through expertise in clinical programs, pharmacy leadership and formulary management. Cardinal also is invested in educating future professionals, with 29 PGY-1 residency positions at its hospitals and eight Doctor of Pharmacy students precepted annually by the Clinical Affairs group.
The resident position will be based in the Clinical Affairs group in Houston, TX. The resident will have a dedicated computer and work space as well as access to several online medical journals and the University of Illinois Drug Information Center. The Clinical Affairs group is comprised of three clinical pharmacy specialists (Oncology, Infectious Disease, and Cardiology), two generalists, and a data and analytics team, which is comprised of a pharmacist and a technical analyst. The group is responsible for providing clinical support materials and formulary management guidance for the Pharmacy Services hospitals.
Oscar Guzman, Pharm.D., BCPS, Clinical Director of Critical Care and Infectious Diseases Performance and Outcomes, will be responsible for coordinating the activities of the resident. In addition, the resident will interact remotely with members of the Cardinal Health Infectious Diseases Advisory Group (IDAG). The IDAG is comprised of 10 clinical pharmacists and infectious diseases specialists that meet via webex every six weeks to discuss contemporary issues that are impacting acute care hospitals.
The resident will be involved in all activities that pertain to infectious diseases, including reviewing new anti-infectives and developing formulary position statements, developing clinical support materials for acute-care hospitals (such as anti-infective stewardship and the treatment of multi-drug resistant organisms), and working with the data and analytics group to analyze patterns of anti-infective use and resistance. In addition, the resident will have the opportunity to travel to community-based hospitals and conduct antibiotic streamlining workshops for the pharmacy staff, which will provide the resident with exposure to the non-academic institutional setting.
The resident also will work with Angela Gomez, Ph.D., Manager of Clinical Education and Training, to develop a webcast for acute-care hospitals on a contemporary ID topic. These webcasts typically are attended by 150 to 200 pharmacists from around the nation. Finally, the ID resident also will have the opportunity to conduct epidemiology-related research and have access to several data sets that include both financial and clinical data.
St. Luke's Episcopal Hospital
St. Luke's Episcopal Hospital (SLEH), a tertiary care teaching hospital, serves as an integral part of the Texas Medical Center, contributing to the enhancement of community health by delivering superior value in high-quality, cost-effective acute care. St. Luke's Episcopal Hospital serves both the greater Houston area and the global community. In partnership with the medical staff, SLEH is dedicated to excellence and compassion in caring for the whole person - mind, body, and spirit. SLEH also is committed to the growth and development of employees, and to securing the health of future generations by creating, applying, and disseminating health knowledge through education and research.
St. Luke's is home to the Texas Heart Institute, consistently ranked among the top 10 cardiology and heart surgery centers in the nation by U.S. News and World Report. The St. Luke's Episcopal Hospital Department of Pharmacy provides all contemporary services with an emphasis on being a pharmacist-centered pharmacy in a patient-centered hospital.
The pharmacy infectious diseases team at SLEH includes full-time clinical specialist Hannah Palmer, Pharm.D., and UHCOP faculty members Kevin Garey, Pharm.D., M.S.; Dhara Shah, Pharm.D., BCPS; and Vincent Tam, Pharm.D., BCPS (AQ ID). The I.D. team is responsible for providing pharmaceutical care services to the ICU and general ward patients. The team also serves as the pharmacy component of the hospital's antimicrobial stewardship program (the SLEH Center for Antimicrobial Stewardship and Epidemiology, which was recognized as a 2010 ASHP Best Practices site). In addition, numerous infectious diseases clinical research studies are conducted by this group. The resident will take part in all aspects of the clinical duties at SLEH and will have opportunities to work with each member of the team.